Search Results

Cover Focus

Drug Delivery: Pearls and Projections

Contributors comment on the present use and future potential of this treatment approach.

Malik Y. Kahook, MD; Jason Bacharach, MD; Courtney Bovee, MD; Savak Teymoorian, MD, MBA; John P. Berdahl, MD; Constance Okeke, MD, MSCE; and Steven R. Sarkisian Jr, MD

Seen & Heard

Global Perspectives

Achieving More Sustainable Outreach

Which practices are most sustainable for addressing unmet needs and empowering local ophthalmologists?

Ivo Ferreira, MD; Malik Y. Kahook, MD; Jason Penniecook, MD; Jeff Pettey, MD, MBA; and Oluwatosin Smith, MD

Cover Focus

Glaucoma Visionaries: Malik Y. Kahook, MD

Malik Y. Kahook, MD

The Literature

Eye Care in the Era of COVID-19

Two studies have implications for improving the safety of patients and providers during the current pandemic.

Cara E. Capitena Young, MD, and Malik Y. Kahook, MD

Spotlight on Teleophthalmology

Pearls and Practices for Virtual Eye Care

Sophie D. Liao, MD; Eimi Rodriguez-Cruz, BS; Malik Y. Kahook, MD; and Cara E. Capitena Young, MD

Cover Focus

Five Pointers on Malignant Glaucoma

Prompt recognition and treatment are essential to reduce the risk of vision loss.

Jeffrey R. SooHoo, MD; Leonard K. Seibold, MD; and Malik Y. Kahook, MD

Feature

William F. Wiley, MD

Interviewed by Laura Straub, Editor-in-Chief, CRST/CRST Europe

Feature

John P. Berdahl, MD

Interviewed by Callan Navitsky, Editor-in-Chief,
Glaucoma Today and MillennialEYE

Fill a Need

Enhancing adherence to glaucoma therapy with punctal plug drug delivery platforms.

Malik Y. Kahook, MD; Jeffrey R. SooHoo, MD; and Leonard K. Seibold, MD

Fill a Need

Enhancing adherence to glaucoma therapy with punctal plug drug delivery platforms.

Malik Y. Kahook, MD; Jeffrey R. SooHoo, MD; and Leonard K. Seibold, MD

The Literature

The Literature

Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD

The Literature

The Literature

Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD

Glaucoma Drugs in the Pipeline

Physicians share which coming therapies they are most eager to use in their practices.

Malik Y. Kahook, MD; Paul L. Kaufman, MD; Robert J. Noecker, MD, MBA; and Nathan M. Radcliffe, MD

Glaucoma Drugs in the Pipeline

Physicians share which coming therapies they are most eager to use in their practices.

Malik Y. Kahook, MD; Paul L. Kaufman, MD; Robert J. Noecker, MD, MBA; and Nathan M. Radcliffe, MD

Challenging Cases

Management of Hypotony After Device Implantation

Jeffrey R. SooHoo, MD; Leonard K. Seibold, MD; and Malik Y. Kahook, MD

Challenging Cases

Management of Hypotony After Device Implantation

Jeffrey R. SooHoo, MD; Leonard K. Seibold, MD; and Malik Y. Kahook, MD

Peer Review

The Role of 24-Hour IOP Monitoring in Glaucoma

Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.

Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD

Peer Review

The Role of 24-Hour IOP Monitoring in Glaucoma

Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.

Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD

Sidebar: Femtosecond Lasers May Have Future Roles in Glaucoma Surgery

Malik Y. Kahook, MD